AAAAAA

   
Results: 1-10 |
Results: 10
Role of short-term inhibition of factor Xa by FXV673 in arterial passivation: A study in a chronic model of thrombosis in conscious dogs
Authors: Rebello, SS Kasiewski, CJ Wang, W Bentley, RG Morgan, SR Chu, V Colussi, D Brown, K Perrone, MH Leadley, RJ
Citation: Ss. Rebello et al., Role of short-term inhibition of factor Xa by FXV673 in arterial passivation: A study in a chronic model of thrombosis in conscious dogs, J CARDIO PH, 38(2), 2001, pp. 288-297
Superiority of enoxaparin over heparin in combination with a GPIIb/IIIa receptor antagonist during coronary thrombolysis in dogs
Authors: Rebello, SS Kasiewski, CJ Bentley, RG Morgan, SR Chu, V Bostwick, JS Klein, SI Perrone, MH Leadley, RJ
Citation: Ss. Rebello et al., Superiority of enoxaparin over heparin in combination with a GPIIb/IIIa receptor antagonist during coronary thrombolysis in dogs, THROMB RES, 102(3), 2001, pp. 261-271
Antithrombotic efficacy of a novel factor Xa inhibitor, FXV673, in a canine model of coronary artery thrombolysis
Authors: Rebello, SS Bentley, RG Morgan, SR Kasiewski, CJ Chu, V Perrone, MH Leadley, RJ
Citation: Ss. Rebello et al., Antithrombotic efficacy of a novel factor Xa inhibitor, FXV673, in a canine model of coronary artery thrombolysis, BR J PHARM, 133(7), 2001, pp. 1190-1198
Contribution of in vivo models of thrombosis to the discovery and development of novel antithrombotic agents
Authors: Leadley, RJ Chi, LG Rebello, SS Gagnon, A
Citation: Rj. Leadley et al., Contribution of in vivo models of thrombosis to the discovery and development of novel antithrombotic agents, J PHARM TOX, 43(2), 2000, pp. 101-116
Role of extracellular ionized calcium in the in vitro assessment of GPIIb/IIIa receptor antagonists
Authors: Rebello, SS Huang, J Faul, JD Lucchesi, BR
Citation: Ss. Rebello et al., Role of extracellular ionized calcium in the in vitro assessment of GPIIb/IIIa receptor antagonists, J THROMB TH, 9(1), 2000, pp. 23-28
Antithrombotic efficacy of single subcutaneous administration of a recombinant nematode anticoagulant peptide (rNAP5) in a canine model of coronary artery thrombolysis
Authors: Rebello, SS Blank, HS Lucchesi, BR
Citation: Ss. Rebello et al., Antithrombotic efficacy of single subcutaneous administration of a recombinant nematode anticoagulant peptide (rNAP5) in a canine model of coronary artery thrombolysis, THROMB RES, 98(6), 2000, pp. 531-540
Thrombostatin inhibits induced canine coronary thrombosis
Authors: Hasan, AAK Rebello, SS Smith, E Srikanth, S Werns, S Driscoll, E Faul, J Brenner, D Normolle, D Lucchesi, BR Schmaier, AH
Citation: Aak. Hasan et al., Thrombostatin inhibits induced canine coronary thrombosis, THROMB HAEM, 82(3), 1999, pp. 1182-1187
Correlation between the in vivo efficacy of GPIIb/IIIa receptor antagonists (m7E3, MK-383 and DMP-728) and ex vivo platelet inhibition
Authors: Huang, JB Rebello, SS Faul, JD Lucchesi, BR
Citation: Jb. Huang et al., Correlation between the in vivo efficacy of GPIIb/IIIa receptor antagonists (m7E3, MK-383 and DMP-728) and ex vivo platelet inhibition, PHARMACOL, 58(5), 1999, pp. 252-264
Effect of time of 7E3 administration on rt-PA-induced reperfusion: study in a canine model of thrombus-based occlusion-reperfusion
Authors: Rebello, SS Huang, JB Saito, K Saucedo, JF Bates, ER Lucchesi, BR
Citation: Ss. Rebello et al., Effect of time of 7E3 administration on rt-PA-induced reperfusion: study in a canine model of thrombus-based occlusion-reperfusion, EUR J PHARM, 374(3), 1999, pp. 399-410
Temporary and partial inhibition of platelets by SM-20302 prevents coronary artery thrombosis in a chronic canine model
Authors: Huang, JB Rebello, SS Rosenberg, LA Kaneko, M Sakurama, T Lucchesi, BR
Citation: Jb. Huang et al., Temporary and partial inhibition of platelets by SM-20302 prevents coronary artery thrombosis in a chronic canine model, EUR J PHARM, 366(2-3), 1999, pp. 203-213
Risultati: 1-10 |